Work

Clinical benefit from pemetrexed before and after crizotinib exposure in patients with ALK positive non-small cell lung cancer (ALK+ NSCLC).

Year: 2012

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2012.30.15_suppl.7601

Authors: Eamon Berge, Maxon Delee, Xian Lu, Anna E. Barón, Benjamin J. Solomon, Robert Charles Doebele, D Ross Camidge

Institutions: University of Colorado Health, University of Colorado Denver, Peter MacCallum Cancer Centre, Peter MacCallum Cancer Foundation, University of Colorado Cancer Center

Language: English

Topic: Lung Cancer Treatments and Mutations

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2601129807

Cites:

Cited by: 2

Related to: 10